Literature DB >> 15018857

Quantitative detection of human immunodeficiency virus type 1 (HIV-1) proviral DNA in peripheral blood mononuclear cells by SYBR green real-time PCR technique.

Davide Gibellini1, Francesca Vitone, Pasqua Schiavone, Cristina Ponti, Michele La Placa, Maria Carla Re.   

Abstract

BACKGROUND: The persistence of proviral human immunodeficiency virus type 1 (HIV-1) DNA reservoir represents one of the major drawbacks to the total eradication of HIV-1. The quantitative determination of proviral HIV-1 DNA load offers significant therapeutic information, especially when the HIV-1 RNA levels drop below the detectable limits during the highly active retroviral therapy (HAART) treatment. Moreover, the detection of HIV-1 proviral DNA is an important diagnostic marker in the evaluation of HIV-1 infection of newborns of HIV-1 seropositive women.
OBJECTIVE: We evaluated a real-time PCR based on LightCycler technology revealed through SYBR green fluorochrome (SYBR green real-time PCR) to quantify the HIV-1 proviral DNA load in peripheral blood mononuclear cells (PBMC) of HIV-1 seropositive patients. STUDY
DESIGN: Firstly, we assessed the SYBR green real-time quantitative PCR for HIV-1 proviral DNA load detection determining the specificity and sensitivity of the assay using the LightCycler system. Secondly, we tested the performance of our SYBR green real-time PCR on 50 HIV-1 seropositive patients under HAART and 20 blood donors. RESULTS/
CONCLUSIONS: The results of this study showed that our SYBR green real-time PCR is able to detect five copies of the HIV-1 genome. Moreover, our method revealed HIV-1 proviral DNA in all the 50 HIV-1 seropositive patients ( 627 +/- 1068 HIV-1 proviral DNA copies per 10(6) PBMC, with a range of 30-6300 copies), whereas no positive signal was observed in any PBMC blood donors. Our SYBR green real-time PCR represents a sensitive and useful approach that could be applied both in HIV-1 proviral DNA reservoir determination and in HAART monitoring, particularly when the HIV-1 plasmatic RNA is undetectable.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15018857     DOI: 10.1016/S1386-6532(03)00169-0

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  16 in total

Review 1.  Real-time PCR in clinical microbiology: applications for routine laboratory testing.

Authors:  M J Espy; J R Uhl; L M Sloan; S P Buckwalter; M F Jones; E A Vetter; J D C Yao; N L Wengenack; J E Rosenblatt; F R Cockerill; T F Smith
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

2.  TLR7 induces anergy in human CD4(+) T cells.

Authors:  Margarita Dominguez-Villar; Anne-Sophie Gautron; Marine de Marcken; Marla J Keller; David A Hafler
Journal:  Nat Immunol       Date:  2014-11-17       Impact factor: 25.606

3.  In-depth, longitudinal analysis of viral quasispecies from an individual triply infected with late-stage human immunodeficiency virus type 1, using a multiple PCR primer approach.

Authors:  M Gerhardt; D Mloka; S Tovanabutra; E Sanders-Buell; O Hoffmann; L Maboko; D Mmbando; D L Birx; F E McCutchan; M Hoelscher
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  Development of methods for coordinate measurement of total cell-associated and integrated human immunodeficiency virus type 1 (HIV-1) DNA forms in routine clinical samples: levels are not associated with clinical parameters, but low levels of integrated HIV-1 DNA may be prognostic for continued successful therapy.

Authors:  J M Carr; K M Cheney; C Coolen; A Davis; D Shaw; W Ferguson; G Chang; G Higgins; C Burrell; P Li
Journal:  J Clin Microbiol       Date:  2007-02-21       Impact factor: 5.948

5.  Development and assessment of a multiplex real-time PCR assay for quantification of human immunodeficiency virus type 1 DNA.

Authors:  A Beloukas; D Paraskevis; C Haida; V Sypsa; A Hatzakis
Journal:  J Clin Microbiol       Date:  2009-05-06       Impact factor: 5.948

6.  A more precise HIV integration assay designed to detect small differences finds lower levels of integrated DNA in HAART treated patients.

Authors:  Jianqing J Yu; Te Lang Wu; Megan K Liszewski; Jihong Dai; William J Swiggard; Clifford Baytop; Ian Frank; Bruce L Levine; Wei Yang; Theodore Theodosopoulos; Una O'Doherty
Journal:  Virology       Date:  2008-07-22       Impact factor: 3.616

7.  Real-time PCR analysis of HIV-1 replication post-entry events.

Authors:  Jean L Mbisa; Krista A Delviks-Frankenberry; James A Thomas; Robert J Gorelick; Vinay K Pathak
Journal:  Methods Mol Biol       Date:  2009

8.  HIV-1 and recombinant gp120 affect the survival and differentiation of human vessel wall-derived mesenchymal stem cells.

Authors:  Davide Gibellini; Francesco Alviano; Anna Miserocchi; Pier Luigi Tazzari; Francesca Ricci; Alberto Clò; Silvia Morini; Marco Borderi; Pierluigi Viale; Gianandrea Pasquinelli; Pasqualepaolo Pagliaro; Gian Paolo Bagnara; Maria Carla Re
Journal:  Retrovirology       Date:  2011-05-25       Impact factor: 4.602

9.  Different patterns of HIV-1 DNA after therapy discontinuation.

Authors:  Maria Carla Re; Francesca Vitone; Laura Sighinolfi; Pasqua Schiavone; Florio Ghinelli; Davide Gibellini
Journal:  BMC Infect Dis       Date:  2005-09-12       Impact factor: 3.090

10.  Factors associated with HIV-1 proviral DNA loads in patients with undetectable plasma RNA load.

Authors:  Jun Yong Choi; Young Goo Song; Young Hwa Kim; Chang Oh Kim; Myung Soo Kim; Bum Sik Chin; Sang Hoon Han; Suk Hoon Choi; Han Sung Lee; Su Jin Jeong; Heekyoung Choi; June Myung Kim
Journal:  J Korean Med Sci       Date:  2009-02-28       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.